The QualityStocks Daily Wednesday, December 29th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(CYTO) $2.0500 +35.76%

StockRockandRoll(GSPT) $0.1923 +28.17%

TradersPro(PIXY) $1.4200 +26.79%

The QualityStocks Daily Stock List

Social Life Network (WDLF)

QualityStocks and InvestorPlace reported earlier on Social Life Network (WDLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Social Life Network Inc. (OTC: WDLF) is a technology firm that licenses a SaaS internet platform (Social life network software as a Service) to various sports verticals and the residential real estate industry.

Social Life Network Inc. operates in the U.S. and is based in Denver, Colorado. The firm was incorporated in January 2013 and provides an e-commerce and social network system that is cloud-based and can be accessed by a mobile application or web browser that enables end-users to socially connect with their customers to advertise and market their services and products as well as connect with one another.

Social Life Network Inc. engages in offering custom or niche network services that connect consumers and global business professionals in various international subcultures or niche industries, including camping, travel, auto racing, space exploration, soccer, cycling, golf, charity causes, health and fitness, real estate professionals, fishing and hunting and racket sports such as tennis, among many others. The firm also operates and owns hemp and cannabis industry platforms that offer a social network for communicating between consumers and businesses.

Social Life Network Inc. recently released its growth plans, which featured their goals to increase user growth on their platform, the elimination of debt as well as the reduction of annual expenses. The firm’s operation in part as a publicly traded tech incubator also allows it to minimize its expenses, which is important for optimum growth and expansion and is beneficial to the shareholders of the firm.

Social Life Network (WDLF), closed Wednesday's trading session at $0.002, up 33.3333%, on 144,532,558 volume with 473 trades. The average volume for the last 3 months is 143.433M and the stock's 52-week low/high is $0.0013/$0.044.

IMD Companies (ICBU)

PennyStocks24, Xtremepicks, OurHotStockPicks, Pumps and Dumps, OTC Stock Review, smartOTC, Pennystocktweeters.com, QualityStocks, EmergingStockPlays, StockOrange, Penny Stock Rumble, AddictivePennyStocks, HEROSTOCKS, PennyStockRumors.net, VIP STOCK ALERTS, OTCPicks, Stockhunter.us, Fast Moving Stocks, HoleinOneStocks.net, Bullseyestox.com, Bull Trends, VipStockReports, ShazamStocks, Stock Brain, Liquid Pennies, Innovative Marketing, InsideBulls, Investors Chatroom, AwesomeStockPick, EpicVIP Group, Greenbackers, Epic Stock Picks, Center Stage Stocks, Damn Good Penny Picks, ChartPoppers, Blaque Capital Stocks, Promotion Stock Secrets, Value Penny Stocks, TheMicrocapNews, Stocktamer, StockPickVIP, StockPicks, Stockgoodies, Stock Tips Network, Penny Stock Newsletter, RagingStock Bull, MajorPennyStocks, PricelessPenny, PREPUMP STOCKS, Penny Trackers, Penny Stock Professor, Orbit Stocks, MicrocapVoice, MarketWireStocks and SmallCap Fortunes reported earlier on IMD Companies (ICBU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

IMD Companies Inc. (OTC: ICBU) is a holding firm which is engaged in the manufacture, marketing and distribution of equipment for the hydroponics industry. This is in addition to developing and manufacturing environmental controllers.

The firm is based in Tampa, Florida and was incorporated in 1993, on March 31st. It operates through its subsidiaries, which include PCI HeartScan, Optimum Mobile Imaging LLC, Lumz n Blooms Ltd Corp and R-Quest Hydroponics Inc. R-Quest Hydroponics Inc. is a software and hardware manufacturing firm.

The company’s primary products and services lie in the medical diagnostics services and health and fitness nutraceutical markets. The company, which plans to expand into the weight-loss industry, aims to combine the expertise of their team to develop a cohesive force which will boost the firm’s position in the marketplace.

The enterprise provides the new environmental master controller system, which offers management for grow room facilities for indoor gardens. The system, dubbed EMC-5000 also controls and regulates all features of an indoor grow system, including co2 level control, nutrient pumps, fans and light cycles, which promote growth. One of its subsidiaries has a base of consumers in both Canada and the United States. It also provides Optimum Mobile Imaging, which focuses on mobile imaging technology offered to patients.

The firm recently launched a cryptocurrency farming operation in Silicon Slopes. This move will allow the firm to set a standard for cryptocurrency farming as well as enable it to become a leading farming operation in the cryptocurrency market. This will boost its revenue as well as its popularity, which will be beneficial to both its stocks as well as its stakeholders.

IMD Companies (ICBU), closed Wednesday's trading session at $0.0024, up 33.3333%, on 36,229,387 volume with 263 trades. The average volume for the last 3 months is 36.229M and the stock's 52-week low/high is $0.0005/$0.0465.

Bonanza Goldfields (BONZ)

QualityStocks, HyperGrowthStock, AheadoftheBulls.com, OTCPicks, Pennybuster, BestPicksEver, Stockpalooza, StockEgg, Bull in Advantage, CoolPennyStocks, HotOTC, BullRally, Greenbackers, MadPennyStocks, PennyInvest, PennyTrader Publisher, StockRich, Stock Traders Chat, PennyStockVille, Stock Marketing Inc., BreakthroughStocks Team, Stock Rich, SteroidStocks, Penny Invest, ShamrockStocks, Topgun stockpicks, MicrocapVoice, OTC Advisors, Otcstockexchange, OTCtipReporter, PennyStockScholar, PennyStocks24 and SmallCapVoice reported earlier on Bonanza Goldfields (BONZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bonanza Goldfields Corporation (OTC: BONZ) is a mining and mineral exploration stage firm that is focused on exploring and acquiring rare earth elements and gold mineral properties in North America.

The firm has its headquarters in Las Vegas, Nevada and was incorporated in 2008, on March 6th. It provides its services in Arizona and Nevada and mainly explores for zinc, lead, silver and gold. The firm is yet to generate any revenue and its mineral properties include the Chloride Mining District and Tom Reed Tr. of Arizona and the Comstock Mining Districts of Nevada.

The enterprise’s flagship property is the Montezuma Stonewall, which is made up of patented mining claims of 60 acres of land found in the south of Goldfield, Nevada. It owns 2 sets of mineral properties in Arizona, the first being the Hull land and the second, federal mining claims on Bureau of Land Management land. Its project is made of 38 lode claims, which cover 455 acres of private and patented property claims. Both projects contain mineralized and alluvial quartz deposits and some rare earth elements. The company also has a net smelter royalty in production from the Thunder Mountain gold project, which is found between Round and Tonopah Mountain, located in Nevada.

The company recently acquired the Thunder Mountain project as part of an agreement with other related parties. This move will not only allow it to grow the extent of their operations but increase their revenues, which will be good for its growth.

Bonanza Goldfields (BONZ), closed Wednesday's trading session at $0.007, up 22.807%, on 9,986,916 volume with 69 trades. The average volume for the last 3 months is 9.987M and the stock's 52-week low/high is $0.0022/$0.037685.

DarkPulse, Inc. (DPLS)

QualityStocks, Trades Of The Day and InvestorPlace reported earlier on DarkPulse, Inc. (DPLS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DarkPulse, Inc. is a technology-security company. It focuses on the manufacture, sale, installation, and monitoring of laser sensing systems based on its patented BOTDA dark-pulse sensor technology (DarkPulse Technology). The Company uses advanced laser-based monitoring systems to provide quick and accurate monitoring of temperatures, strains, and stresses. DarkPulse continues to explore potential strategic alliances via joint venture (JV) and licensing opportunities to further expand its worldwide market position. DarkPulse is based in New York, New York.

DarkPulse is a leader in distributed fibre sensor solutions. Concerning Mine Safety, through a partnership with The Lowell Institute for Mineral Resources, it has created a real time sensor system, which can detect the location and movement of personnel and equipment throughout a mining operation. With a DarkPulse system, critical temperature, pressure, and strain measurements are made on a continuing basis throughout the Drill String, Casing, Wellhead and Production Trees.

DarkPulse sensor configurations are available for monitoring areas in and around buried or above ground pipelines that are 100 km or more in length, or for localized areas as small as 8 cm in diameter. This system includes the Company’s patented DARKPULSE™ system, which can determine wall deformation, corrosion, pipewall thickness, pressure, strain, and temperature from sensor data collected in Real-Time.

A DarkPulse system provides numerous power sources for continuing monitoring including solar and battery that allows for off- grid installations. It is now available with the Company’s Anywhere Any Device™ user interface capability. The Company’s laser sensing systems provide a data stream of critical metrics for measuring the health and security of infrastructure for applications in border security, pipelines, oil and gas, aviation and aerospace, and mine safety.

At the end of December 2020, DarkPulse announced it appointed Mr. Faisal Farooqui as its Director for Asia-Pacific (APAC) and Middle East and North Africa (MENA) global regions. Mr. Farooqui will establish sales operations for MENA and APAC regions. He is responsible for establishing India & Dubai offices for DarkPulse while tasked with building an engineering and Sales Team.

DarkPulse, Inc. (DPLS), closed Wednesday's trading session at $0.06485, up 21.215%, on 35,938,067 volume with 1,689 trades. The average volume for the last 3 months is 35.938M and the stock's 52-week low/high is $0.0004/$0.202.

Altamira Therapeutics (CYTO)

We reported earlier on Altamira Therapeutics (CYTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Altamira Therapeutics Ltd (NASDAQ: CYTO) is a pharmaceutical firm that is focused on the development of therapeutics that address unmet medical needs.

The firm has its headquarters in Hamilton, Bermuda and was incorporated in April 2003 by Thomas Meyer. Prior to its name change in July 2021, the firm was known as Auris Medical Holding Ltd.

The company operates primarily in Basil, Switzerland. It operates through its Australia and Switzerland geographical segments. The company serves consumers around the globe.

The enterprise’s product pipeline comprises of a formulation known as Sonsuvi, which is undergoing a phase 3 clinical trial evaluating its effectiveness in treating acute inner ear hearing loss; a formulation dubbed Keyzilen, which is undergoing a phase 3 clinical trial testing its efficacy in treating acute inner ear tinnitus; and AM-125, which is undergoing phase 2 clinical development for the intranasal treatment of vertigo. It also develops RNA therapeutics for extrahepatic therapeutic targets, which include its SemaPhore and OligoPhore platforms, which are in their preclinical stage for mRNA delivery and oligonucleotide. In addition to this, the enterprise is involved in the development of a drug-free nasal spray known as Bentrio, which has been designed to offer personal protection against airborne allergens and viruses.

The company’s Bentrio formulation which had filed for premarket clearance has been cleared by the FDA. This move brings the formulation and the company one step closer to entering the U.S. market, which will not only bring in additional revenue into the company but also encourage more investments into the firm.

Altamira Therapeutics (CYTO), closed Wednesday's trading session at $2.05, up 35.7616%, on 23,144,347 volume with 47,950 trades. The average volume for the last 3 months is 22.676M and the stock's 52-week low/high is $1.21/$6.25.

Two Hands Corp (TWOH)

Penny Stock General, Shiznit Stocks, QualityStocks, StockRockandRoll, Penny Stock 101, PennyStockLocks, Penny Stock Titans, Profitable Trader Authority, OTCtipReporter, Penny Picks, PennyStockScholar, Damn Good Penny Picks, Small Cap Firm, Fierce Analyst, Stock Commander, PennyStockProphet, StockWireNews, GrowthPennyStocks, Penny Pick Finders, BeatPennyStocks, StockOnion, Buzz Stocks, Epic Stock Picks, Monster Alerts, HotOTC, Wolf of Penny Stocks, Make Penny Stocks Great Again, MicroCapDaily, MassiveStockProfits, Insider Financial, InvestorSoup, Beacon Equity Research, Penny Stock Finder, ProTrader, Stock Preacher, StockHideout, StockStreetWire, Penny Stock Craze, OTCMagic, Penny Stock 106, Penny Stock Prodigy, PennyStockLocks.com, Explicit Penny Picks, Wealth Insider Alert and Winston Small Cap reported earlier on Two Hands Corp (TWOH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Two Hands Corp (OTC: TWOH) is a custom application development firm that is focused on the research and development of software applications.

The firm has its headquarters in Mississauga, Canada and was incorporated in 2009, on April 3rd by Doug Clark. Prior to its name change in September 2016, the firm was known as Innovative Product Opportunities Inc. It serves consumers in Canada.

The enterprise oversees the research, planning, pricing, creative development, tracking and deployment of its diversified solutions to firms in North America. One of its divisions, Gocart.city, is an online grocery delivery marketplace. The division is focused on curating and delivering specialty foods and the freshest produce in Southern Ontario. The enterprise’s other on-demand branches include Cuore Food services and Grocery Originals. Cuore Food operates as its wholesale food distribution branch. Grocery Originals is the firm’s brick-and-mortar grocery store, situated in Mississauga Ontario at the site of the firm’s warehouse. In addition to this, the enterprise offers an encrypted messaging application dubbed Two Hands Gone. Furthermore, it provides fresh-cut, individually packaged vegetables and fruits; Italian themed products like wine, coffee, tea, desserts, pasta and oils; specialized foods, which include gluten-free, artisan and health conscience items; and accessories like aprons, candles, table clothes, tableware and plates.

The company is focused on expanding into new locations, growing its grocery category to more than 2700 items as well as its customer base. In addition to this, it is focused on expanding its delivery area to better meet its customer demand.

Two Hands Corp (TWOH), closed Wednesday's trading session at $0.001, up 25%, on 119,606,139 volume with 181 trades. The average volume for the last 3 months is 119.606M and the stock's 52-week low/high is $0.0007/$0.0097.

Syrah Resources (SYAAF)

InvestorPlace and MarketBeat reported earlier on Syrah Resources (SYAAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Syrah Resources Limited (OTC: SYAAF) (FRA: 3S7) (ASX: SYR) is a mineral exploration firm that is focused on exploring for, evaluating and developing mineral properties.

The firm has its headquarters in Melbourne, Australia and was incorporated in 2007, on July 23rd. It operates as part of the non-metallic mineral mining and quarrying industry, under the natural resources sector. The firm has seven companies in its corporate family and serves consumers around the globe.

The company operates through the Corporate, Vidalia and Balma segments. The corporate segment is involved in investing activities like the development of its battery anode material strategy, as well as corporate administration. The Vidalia segment is focused on the production of natural graphite active anode material to service ex-Asia markets. On the other hand, the Balma segment is involved in the mining, mineral exploration, evaluation and development activities associated with its Mozambique graphite project. The company operates through the Americas, India, Europe, China and Asia geographical segments. It generates most of its revenue from the Balama segment.

The enterprise’s projects offer exposure to uranium, coal, copper, mineral sands, vanadium and graphite. They include the Sphercial graphite project; the Balma project;and the Balama project, which produces vanadium and natural flake graphite. The Balama project is located in the Cabo Delgado province of Mozambique.

The firm recently entered into a 4-year supply deal agreement with Tesla, which entails the supply of graphite anode materials to the electric car manufacturer. This move will not only bring in significant revenue into the firm but also more investors into the firm, which will have a positive influence on the company’s growth.

Syrah Resources (SYAAF), closed Wednesday's trading session at $1.26, off by 25.4438%, on 485,097 volume with 405 trades. The average volume for the last 3 months is 485,097 and the stock's 52-week low/high is $0.7064/$2.48.

SIFCO Industries (SIF)

SmarTrend Newsletters, StockMarketWatch, TradersPro, StreetInsider, MarketBeat, Street Insider, QualityStocks, PoliticsAndMyPortfolio.com, Money Morning and MarketClub Analysis reported earlier on SIFCO Industries (SIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SIFCO Industries Inc. (NYSE American: SIF) (FRA: SI7) is focused on the production, sale and marketing of machined components, sub-assemblies and forgings for the energy and aerospace markets.

The firm has its headquarters in Cleveland, Ohio and was incorporated in 1913. It serves consumers around the globe, with a focus on Europe and North America.

The company’s manufacturing facilities are located in Maniago, Italy; Orange County, California and Cleveland, Ohio. Most of its revenue is derived from its North American segment.

The enterprise’s processes and services include machining, heat-treating and forging. It provides original equipment and spare components for industrial and aircraft gas turbine engines; rotating components for helicopters; aircraft brakes and wheels; aircraft landing gear components; structural airframe components; steam turbine blades; and other industrial/commercial products. Its products range in size from about 2 to 1,200 pounds and are made of aluminum, titanium, stainless steel and steel. In addition to this, it offers non-destructive testing, surface treatment, heat treatment and select machining and sub-assembly of forged components. The enterprise serves both aftermarket and original equipment manufacturer customers, as well as the global airline and aerospace industries through its network of service, manufacturing and distribution centers in the Far East, Europe and the United States.

The company recently announced its latest financial results, with its CEO noting that they remained focused on serving consumers across the energy and aerospace markets, growing the company’s content on major platforms and seeking opportunities in adjacent markets which would be good for the company’s growth.

SIFCO Industries (SIF), closed Wednesday's trading session at $6.015, up 0.434129%, on 5,843 volume with 78 trades. The average volume for the last 3 months is 5,843 and the stock's 52-week low/high is $5.30/$15.7583.

Genocea Biosciences (GNCA)

MarketClub Analysis, MarketBeat, StockMarketWatch, TraderPower, QualityStocks, Jason Bond, BUYINS.NET, INO Market Report, StreetInsider, Marketbeat.com, Schaeffer's, Zacks, Seeking Alpha, Barchart, PoliticsAndMyPortfolio, Stock Beast, Technology Profits Daily, The Street, TopStockAnalysts, Trades Of The Day, FreeRealTime, Daily Trade Alert, Wall Street Mover and Promotion Stock Secrets reported earlier on Genocea Biosciences (GNCA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Genocea Biosciences Inc. (NASDAQ: GNCA) (OTC: GGNNW) (FRA: GBI1) is a biopharmaceutical firm that is focused on the discovery and development of new cancer immunotherapies.

The firm has its headquarters in Cambridge, Massachusetts and was incorporated in 2006, on August 16th by Kevin J. Bitterman and Robert Paul. It serves consumers in the United States.

The company is focused on building a pipeline of immunotherapies for infectious diseases with unmet needs. It uses ATLAS, its proprietary technology platform, to identify antigens of T cells which are clinically relevant based on human immune responses. The company operates through one segment: Vaccine development and commercialization. It seeks to partner with other companies to develop a vaccine that targets cancer caused by the Epstein-Barr virus as well as general cancer vaccines.

The enterprise’s product pipeline comprises of a neo-antigen cancer vaccine candidate dubbed GEN-009 which has been designed to deliver synthetic long peptides spanning anti-tumor neoantigens. It also develops an adoptive T cell therapy known as GEN-011 using neoantigen-targeted peripheral cells which are utilized in the manufacture of blood-derived tumor-specific T cell therapy. In addition to this, the enterprise develops an investigational immunotherapy dubbed GEN-003 indicated for the treatment of genital herpes.

The global breast cancer treatment market is expected to grow at a compounded annual growth rate of about 8.5%, generating revenues worth about $34 billion by the year 2026. This will afford the firm various expansion opportunities and position it for exponential growth in the market that is expected to expand at a rapid rate in the Asia Pacific region.

Genocea Biosciences (GNCA), closed Wednesday's trading session at $1.21, off by 0.819672%, on 1,000,309 volume with 3,044 trades. The average volume for the last 3 months is 1M and the stock's 52-week low/high is $0.9101/$4.045.

Berkshire Grey Inc. (BGRY)

MarketBeat, Trades Of The Day and Daily Trade Alert reported earlier on Berkshire Grey Inc. (BGRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Berkshire Grey Inc. (NASDAQ: BGRY) is an intelligent enterprise robotics firm is engaged in the provision of AI-enabled robotic solutions.

The firm has its headquarters in Bedford, Massachusetts and was incorporated in 2013, on October 3rd. Prior to its name change, the firm was known as Revolution Acceleration Acquisition Corp. It operates as part of the computer systems design and related services industry. The firm has six companies in its corporate family and serves consumers around the globe, with a focus on the United States.

The company is focused on pioneering and delivering transformative AI-enabled robotic solutions which automate supply chain operations. It provides its solutions to logistics fulfillment centers and automated warehouses.

The enterprise assists its customers by delivering technology that combines robotics and AI to automate logistics, supply chain and fulfillment operations. Its solutions transform sort, organize, store, move, pack and pick operations for enterprises that serve connected customers. This is in addition to handling stock-keeping units of other solutions and assisting in fulfilling pick, pack and ship e-commerce orders. The enterprise’s technologies include Electromechanicals, Mobile robotics, AI software and Robotic picking. Its customers include parcel and package logistics, third-party logistics, grocery, convenience, e-commerce and retailers.

The company recently introduced its next generation robotic product solution which will address various labor-intensive processes consumers face. This move accelerates the adoption of automation technology and will have a positive effect on investments and revenues into the company, as well as the company’s overall growth.

Berkshire Grey Inc. (BGRY), closed Wednesday's trading session at $4.92, off by 3.1496%, on 1,470,740 volume with 10,600 trades. The average volume for the last 3 months is 1.471M and the stock's 52-week low/high is $4.12/$10.545.

AGM Group (AGMH)

StockMarketWatch, BUYINS.NET and QualityStocks reported earlier on AGM Group (AGMH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AGM Group Holdings Inc. (NASDAQ: AGMH) is an integrated technology firm that is focused on the provision of financial solutions.

The firm has its headquarters in Wan Chai, Hong Kong and was incorporated in 2015, on April 27th by Wen Jie Tang and Zhen Tao Jiang. It serves consumers around the globe, with a focus on Asia and the United States.

The company operates through the following businesses: its program trading application technology and management service business, its forex trading brokerage business and its online trading and computer support service business. It is party to a strategic partnership with High Sharp Electronic Technology Co Ltd.The company is focused on delivering financial technologies and trading platform solutions to institutional clients and brokers.

The enterprise provides an interactive trading education website which uses the subscription-based method, and multi-assets trading and management systems to mid-size and small broker and institutional clients. Its online trading education and social trading network platform dubbed FXSC has been designed for forex traders. The platform offers trading education to users via trading contests, demo trading services and interactive trading simulation. The enterprise also offers ASIC chip solutions which include crypto miner production, chip research and development and chip design. This is in addition to delivering software customization services and selling technical support plans.

The company recently announced its latest financial results for 2021 which show increases in its revenues and profit. It is focused on using its new growth strategy to become a leader in the production of high-power ASIC mining machines, which will positively influence the company’s growth.

AGM Group (AGMH), closed Wednesday's trading session at $2.76, off by 7.0707%, on 304,501 volume with 1,328 trades. The average volume for the last 3 months is 304,501 and the stock's 52-week low/high is $2.63/$26.50.

Titan International, Inc. (TWI)

Zacks, StreetAuthority Daily, StreetInsider, SmarTrend Newsletters, The Street, InvestorPlace, Wall Street Resources, MarketBeat, TradersPro, Marketbeat.com, TopStockAnalysts, StockMarketWatch, Rick Saddler, Market Intelligence Center Alert, QualityStocks, TradingMarkets, BUYINS.NET, CrashTrade, Daily Wealth, Darwin Investing Network, Dividend Opportunities, Dynamic Wealth Report, FNNO Newsletters, Red Chip, WStreet Market Commentary, Schaeffer's, Trading Concepts, The Motley Fool, MarketClub Analysis, ProfitableTrading, BestOtc, Stockhouse, Short Term Wealth and Forbes reported earlier on Titan International, Inc. (TWI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Price Target Raised; Estimates Raised

Titan International, Inc. (NYSE: TWI) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Raise Price Target To $15 (From $13), As We Lift Our 2021-2023 EPS Estimates On Rallying Crop Prices, The Industry’s Healthy Order Book And The Chairman’s Positive Outlook.”

Click here to access the full report.

About Titan International, Inc.

Titan International is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in Illinois, the company globally produces a broad range of products to meet the specifications of original equipment manufacturers (OEMs) and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. Please visit www.titan-intl.com.

Titan International, Inc. (TWI), closed Wednesday's trading session at $10.93, up 0.923361%, on 792,594 volume with 6,825 trades. The average volume for the last 3 months is 792,278 and the stock's 52-week low/high is $4.68/$11.82.

The QualityStocks Company Corner

Sanwire Corp. (SNWR)

The QualityStocks Daily Newsletter would like to spotlight Sanwire Corp. (SNWR).

Sanwire Corp. (SNWR) is a diversified company currently focused on technologies for the music industry. The company specializes in locating unique opportunities in fragmented markets and implementing its aggregated technologies to consolidate distinct services into unified platforms of delivery. Sanwire is currently focusing these efforts on advanced entertainment technologies.

Founded in 1997 and based out of Las Vegas, Nevada, Sanwire has operated and sold several subsidiaries as it has worked in various industry segments, including Sanwire Software Inc., Bullmoose Mines Ltd. and Squeeze Report Inc. Currently, there are two new holdings that were added to the company’s portfolio through two recent acquisitions, including Intercept Music Inc. in March 2020 and the Art is War Record Label in June 2020.

Intercept Music Inc. – Artist-Focused Services

Intercept Music Inc. is an entertainment technology company offering a unique suite of artist-focused services that are specifically designed to meet the needs of recording artists. Intercept’s proprietary online platform is dedicated to helping millions of global independent artists effectively promote their music and distribute it worldwide to hundreds of digital stores and every major streaming platform, including Spotify, Apple Music, Amazon Music, Pandora and Google Music.

With Intercept Music, recording artists have all the tools needed to market, promote and sell their music online and through social media. Comprehensive reporting allows artists to track the fan response to their releases, all the way down to individual music tracks.

There are three foundations of Intercept Music’s product offering:

  • Its music distribution platform that is well augmented via the company’s partnership with InGrooves, a wholly owned subsidiary of Universal Music, which is arguably one of the largest music companies in the world.
  • Its social media system, which is tailored to work the way artists use social media to promote their music and engage with their fans. The scheduling system integrates artists’ profiles across multiple social networking sites (Facebook, Twitter, Instagram and YouTube) to facilitate new audience sampling, fan development and the ability for music to be previewed and purchased.
  • The third is represented by the team of developers that brings a unique combination of deep technical expertise (in products like Skype), a team of well-accomplished executives and what the company calls Brand Ambassadors – senior reps from multiple genres who have helped artists earn over 100 Grammys.

Intercept Music is the confluence of technology and this music expertise.

The company currently markets three plans to its clients, with each offering different distribution and royalty options, as well as various marketing and reporting options. The plans are described below:

  • Intercept Distro is a basic plan for self-service music distribution with royalty collection. Artists keep 100% of the royalties while receiving unlimited releases and full analytics with reporting.
  • Intercept Artist includes all of the benefits of the basic Distro plan with added emphasis on social marketing and distribution for emerging artists. With this plan, artists receive scheduled and ad-hoc posting, social media reporting, reusable content libraries and access to other valuable features.
  • Intercept PLUS is available by invite only and is for established artists looking for a complete suite of marketing, distribution and monetization services. The PLUS plan includes everything available through the Distro and Artist plans, as well as offering a dedicated service representative, a branded online store, on-demand merchandise, additional marketing, YouTube monetization and other pro features.

Intercept PLUS is the flagship plan. Artists of this caliber often do $3-$10k/month in merchandise sales alone, at 50%+ profit. Intercept is responsible for marketing to the fan base through its social media system and shares in the profits generated. The stores are managed by intercept so both top-line revenues and bottom-line profits flow through Intercept.

Intercept Music has partnered with Ingrooves Music Group, the largest online music distribution company in the world, for worldwide distribution to streaming services and leading stores. Completing more than 50 billion transactions weekly across over 150 countries, Ingrooves supplies music to leading streaming music platforms and lists some of the world’s largest and most reputable music labels among its clients. The partnership allows Intercept Music and its clients to reach a much wider audience and start earning revenue as soon as possible by leveraging Ingrooves’ quality control systems and direct relationships with leading music streaming services.

Physical Distribution Options for Intercept Music Clients

In a press release on June 25, 2020, Intercept Music announced that it would be offering artists physical distribution through major retailers such as Amazon, FYE and Walmart (http://nnw.fm/NSrbE). The physical distribution will consist of CDs and vinyl and will serve as a supplement to the online streaming platform access provided by the company to represented artists.

“In the current climate, artists can’t play shows or otherwise engage in public at all, so they’re focusing on all other opportunities to bring in revenue,” Intercept Music President Tod Turner stated in a news release. “Our only priority is to help artists monetize music in every way, and with physical distribution added to the mix, we’re leaving no stone unturned in helping artists to earn money from their creative output.”

Creation of Preferred Stock

On June 29, 2020, Sanwire CEO Christopher Whitcomb announced that the company would be filing certificates of designation with the Nevada Secretary of State for its Series A, B and C preferred stock (http://nnw.fm/svrQt).

Speaking about this designation in a news release, Whitcomb stated, “Our paramount goal is to maintain a balanced approach between future investments and shareholder value while minimizing shareholder dilution. The effective utilization of preferred stock ensures our company can grow with the least amount of shareholder dilution.”

Sanwire is leveraging a multi-dimensional strategy that includes additional acquisitions, attracting investors and enhancing the current balance sheet while minimizing dilution for shareholders. A primary goal of these efforts is to support Intercept’s ongoing operations.

Financial Highlights

For the fiscal quarter ended June 30, 2020, Sanwire announced significant revenue growth related to the acquisitions of Intercept Music and Art is War Records. Since acquiring Intercept Music in March and Art is War Records in June, Sanwire’s revenue has increased by approximately 300% (http://nnw.fm/j0S0j). Sanwire attributes the increase in revenue to Intercept Music’s customer acquisition and the release of its PLUS plan.

For the third quarter, revenue is expected to continue an upward climb, owing largely to physical distribution plans and a rising number of PLUS subscribers. The company’s acquisition of Art is War Records is also expected to fuel this growth.

Management

Christopher M. Whitcomb is the current CEO of Sanwire Corp. and Intercept Music Inc. He is a CPA in the state of California, holding bachelor’s degrees in accounting, corporate finance and business management with a focus on real estate. A seasoned executive, his business ventures are always strongly focused on the development and financing of companies.

Whitcomb worked alongside Ralph Tashjian at SMC Entertainment Inc. and Digital Music Universe. They are currently working together again following Sanwire’s acquisition of Intercept Music, which was founded by Tashjian.

Sanwire Corp. (SNWR), closed Wednesday's trading session at $0.009, up 1.9253%, on 175,364 volume with 8 trades. The average volume for the last 3 months is 175,364 and the stock's 52-week low/high is $0.005/$0.039.

Recent News

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF)

The QualityStocks Daily Newsletter would like to spotlight StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF).

  • StraightUp is expected to benefit from increased interest in precious metals as investors, traders, and savers rush into gold and silver markets to hedge against inflation, which has risen to its highest point since 1982
  • Economists expect that the strong inflation will continue driving buyers into gold and other precious metals
  • StraightUp is acquiring various gold and silver mineral property assets in historically prolific regions of both North and South America

The latest data released December 10 by the Bureau of Labor Statistics show the US inflation rate rose to 6.8%, its highest point since 1982, on the back of higher housing, food, and gas prices. The price hikes are attributable to the pandemic, which disrupted and continues to affect manufacturing and shipping. At the same time, Americans have more cash to spend due to the US government’s stimulus payment program. This has burdened supply chains even further, bumping up inflation numbers (https://ibn.fm/90wSw). Economists expect that strong inflation will continue to drive buyers into gold, while others observe that the Fed’s hands are tied – any remedial efforts are only likely to compound the situation. As this happens, the gold market is expected to continue on a bullish trend, with the resultant price rally expected to benefit StraightUp Resources (CSE: ST) (OTCQB: STUPF), a public company engaged in mineral exploration as well as the acquisition of mineral property assets with significant potential in North and South America.

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) is a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America. The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals.

The mission of StraightUp Resources is to maximize shareholder wealth through mineral discoveries at projects with robust potential, maintain long-lasting partnerships, and continue to focus on the acquisition, development and exploration of mineral resource properties in North America. The company’s objective is to continue to locate and develop economic, precious and base metal properties of merit.

The company’s 10,000-hectare (almost 25,000 acres) RLX Projects are contiguous to various Evolution Mining, Great Bear Resources, Pacton Gold and Dixie Gold properties. Its 2,000-hectare (just under 5,000 acres) Belanger Project is contiguous to Infinite Ore’s Fredart and Garnet/Arrow properties. StraightUp intends to conduct exploration on the RLX North, RLX South, Belanger and Ferdinand Gold properties located in the Red Lake District, a location touted as having one of the best metal-endowed greenstone belts in the world. The Bear Head Gold Project is located within the Meen-Dempster Greenstone Belt of the Uchi Subprovince, approximately 80 kilometers west of the Pickle Lake Gold Camp and 14 km northeast of the former gold mine, Golden Patricia. It amassed 620,000 ounces of gold at an average of 15.2 g/t Au from 1988-1997. The property is bordered by an Australian miner massive gold project. Known gold occurrences are already mapped on the Bear Head property, as are previous drill holes and results. Once the data is re-examined, an exploration budget and subsequent plans will be announced by the company.

Projects

Ontario’s Red Lake Mining District is one of Canada’s most prolific gold mining districts, renowned for its high-grade gold deposits. This is a mining-friendly, politically stable jurisdiction with a skilled labor force and infrastructure specifically built around meeting the needs of the mining industry.

RLX North & South Projects
At over 10,000 hectares, the RLX North and RLX South Projects represent a district-scale exploration opportunity. The RLX North and RLX South Projects are well positioned on-strike to the southeast of the district’s largest gold deposit (Red Lake Gold Mines – Evolution Mining). The project is adjacent to Great Bear Resources’ Sobel Project. Great Bear Resources is also in the process of evaluating the area for significant regional-scale structural controls and has proposed additional work on its neighboring project in the near term. These properties are highly accessible, with the southern boundary only eight kilometers from the paved highway into Red Lake, and can be accessed by forest service roads which traverse throughout the properties.

Belanger Project
Historic exploration work on the 2,000-hectare property has identified three significant surface exposures of gold, copper and silver. Early exploration work will focus on validating historic sampling results and following the occurrences along strike with a view to better understanding the nature and controls on mineralization. The property has excellent forest road access from the town of Ear Falls.

Ferdinand Gold Project
The Ferdinand property is situated within the southeastern extension of the Confederation-Uchi greenstone belt, one of the most metal-endowed greenstone belts in the world by square kilometer. It consists of 17 contiguous mining claims covering approximately 7,143 hectares (17,650 acres), located 13 kilometers northwest of the town of Slate Falls. Access is currently by logging roads, with forestry logging operations scheduled for expansion on the property. StraightUp recently completed a heliborne magnetic survey consisting of 1,994 line-km at 50m line spacings covering the entire property. The MAG survey was designed to provide geological and structural details of a 25km long southeast extension of the Confederation-Uchi greenstone belt along the Fry-Bamaji Deformation Zone.

Bear Head Gold Project
The Bear Head Gold Project comprises 31 mining claims totaling 1,944 hectares (4,800 acres) in the Meen-Dempster Greenstone Belt of the Uchi Subprovince, host to the Golden Patricia former gold mine, which produced 620,000 ounces of gold from 1988 to 1997. The Dorothy Main gold deposit owned by Ardiden lies only one kilometer from the Bear Head Gold Project. The Dorothy Main gold deposit holds noncompliant historical resources of 46,600 ounces of gold at 6.17 g/t Au. The company looks forward to adding the Bear Head Gold Project to its exploration efforts, with a work program to be conducted later in the fall of 2021.

Management Team

Mark Brezer is CEO, President, and Director of StraightUp Resources Inc. He is a successful businessman and holds a Geography/Geology degree from the University of Arizona. He has worked as a Project Manager and has overseen quality control, environmental monitoring and safety programs related to road construction. He has also held roles in media relations and marketing. He has been actively involved in the research and investment of junior mining companies for over 25 years. Time in the field and personal interest led him into extensive first aid training, and he is certified as a paramedic and firefighter.

Daniel Cruz is CFO and Director at StraightUp Resources. He is an experienced financial industry professional, having worked for 12 years as a senior investment advisor at Canadian broker-dealers, where he gained experience in equity research, asset management, investor relations, corporate finance and venture capital. He was one of the youngest Senior Investment Advisors at Canaccord Financial Inc. in 2010. He is also the co-founder and current director of Liquid Media Group Inc., a Nasdaq-listed issuer. During his tenure as CFO, he helped that company list on Nasdaq and raise over $20 million.

Matthew Coltura is a Director at StraightUp Resources. He has a Bachelor of Business Administration from Okanagan College, where he specialized in finance. He has worked in the finance industry for more than three years. Currently, Mr. Coltura is the CFO of Cayenne Capital Corp. He was also a director of PreveCeutical Medical Inc. from July 2016 to September 2019, a director of Sproutly Canada Inc. (formerly Stoneridge Exploration Corp.) from March 2015 to July 2018, and, since March 2018, has worked as a financial specialist at Quip Finance.

StraightUp Resources Inc. (OTCQB: STUPF), closed Wednesday's trading session at $0.11301, off by 4.172%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 2,000 and the stock's 52-week low/high is $0.10676/$0.26.

Recent News

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF)

The QualityStocks Daily Newsletter would like to spotlight Avricore Health Inc. (OTCQB: AVCRF).

  • Pharmacy services developer Avricore Health is establishing a network of lab-grade testing and reporting for select medical conditions through neighborhood pharmacy stores
  • Such neighborhood POC store solutions building empowers patients to work with trained pharmacy professionals in monitoring select health conditions, including virus exposure
  • Viruses have become a focal point of health response efforts during the past two years as COVID-19 SARS-CoV-2 infections have claimed millions of lives and sickened scores of others
  • Avricore has thus far established its pilot program in Canada’s eastern Ontario province and western British Columbia province, anticipating strong growth of the HealthTab network in Canada and internationally in 2023

The global COVID health crisis has illuminated the importance of the medical sciences like never before as the populations of virtually every nation have monitored news updates on the progress of infectious disease rates, visited local health departments to receive vaccinations, and debated the effectiveness of health policy measures on social media. Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is a health diagnostics solutions innovator dedicated to expanding access to lab-grade medical test results for a wide variety of medical conditions, including potential COVID analysis. Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is positioning in an era where point-of-care (“POC”) testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more. In the shift to a more decentralized testing approach, Avricore is taking part in this disruption through its POCT platform, HealthTab(TM), found at select community pharmacies. “HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results,” reads a recent article. “The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and trained health care professionals. In a November 23 announcement, Avricore celebrated the signing of a distribution agreement with Abbott that expanded its platform’s capabilities to better support patients with vital information about their renal function.” Avricore CEO Hector Bremner was quoted on the move as saying, “Understanding renal function in patients at risk from or already living with chronic disease is critical. With i-STAT Alinity and its associated test for creatinine, health care professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.” To view the full article, visit https://ibn.fm/A38CS

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering, HealthTab™ (a wholly owned subsidiary), the company aims to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.

HealthTab

HealthTab is a turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs (sometimes known as ‘Community Diagnostic Centers’, or CDCs) and connects them on a single, cloud-based platform.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery and empowers patients to take more control of their health. It also reduces costs and waiting times while providing many potential revenue streams, including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets and third-party app integration through API.

Agreement with Shoppers Drug Mart

In June 2021, Avricore signed a Master Agreement with select Shoppers Drug Mart pharmacies to pilot the HealthTab platform. This agreement gives patients access to point-of-care blood screening and health-data management for potential risks relating to diabetes and cardiovascular conditions using HealthTab-integrated Afinion 2™ analyzers provided by Abbott Rapid Diagnostics.

Avricore is the first pharmacy solutions provider to partner with Abbott (NYSE: ABT), the global health care company and diagnostics leader in Canada. In May 2021, the company signed a supplier distribution agreement to expand the distribution of Abbott’s Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in Canada. This agreement includes valuable HbA1c testing, a critical marker for the screening and management of diabetes.

Near Term Goals

Near term goals for Avricore include expansion into more pharmacies across Canada, followed soon after by entering the U.S. and UK markets. The company has made significant strides in testing and developing its technology and is moving into the commercialization stage.

Strategic partnerships like those with Abbott and select Shoppers Drug Mart pharmacies advance Avricore closer to becoming an incredibly dominant player in the community diagnostics space. The company aims to make actionable health information more accessible for everyone by creating the world’s largest rapid testing network in pharmacies.

Market Outlook

In 2020, the global point-of-care testing (POCT) market was valued at $34.49 billion and expected to expand at a compound annual growth rate (CAGR) of 9.4 percent to reach a projected $81.37 billion by 2028. This upsurge is expected to be driven largely by increased demand for screening and management tools for chronic diseases, as well as rapidly assessing infectious diseases such as COVID-19.

The accessibility of POCT has been an increasing priority of the world’s leading health organizations and experts. Pharmacies are ideal ‘hubs’ within the community to offer patients better access to the numbers they need to know for preventing or treating conditions such as diabetes and heart disease or the timely diagnosis of infection.

Management Team

Avricore’s leadership team brings a diverse portfolio of expertise across the health care and biotech industries, as well as technology, finance and communications. Together, they share a common vision of moving pharmacy forward and have positioned the company for significant future growth and expansion.

Hector Bremner is the CEO of Avricore. He has over 15 years of senior and executive experience across various industries, including international trade, natural gas, marketing and communications. He owned and operated TOUCH Marketing, a boutique marketing and communications firm based in Vancouver, from 2007 to 2013. Mr. Bremner has also served as the executive assistant to the Deputy Premier and Minister of Natural Gas Development, Responsible for Housing, as well as the Minister of International Trade and Minister of Small Business. In 2015, he joined Vancouver’s Pace Group Communications as VP of Public Affairs.

David Hall is the Chairman and a Director of Avricore. His leadership spans five different companies. He is currently the Chairman of RepliCel Life Sciences and a member of the boards of TrichoScience Innovations, AdvantageBC and Providence Health Care Research Institute. Mr. Hall also served as Chairman of Perceptronix Medical Inc.; Chief Financial Officer, Secretary & Treasurer of Angiotech Pharmaceuticals Inc.; President & Director at Newcastle Resources Ltd.; and Chairman for LifeSciences British Columbia.

Kiki Smith is Avricore’s CFO. She has over 20 years of experience assisting private and public companies in the roles of accountant, corporate controller and CFO in mining, oil & gas, real estate, high technology, food production and investment fund management. She currently provides consulting services in M&A, financial reporting and regulatory compliance to several public and private companies across several investment sectors. Ms. Smith is a member of the Chartered Professional Accountants of British Columbia and has a bachelor’s degree in economics from the University of British Columbia.

Rodger Seccombe is the Head of Avricore’s HealthTab division and the co-founder and former CEO of HealthTab Inc. Mr. Seccombe has over 20 years of experience launching and running companies in software, health care technology and clean energy. He is a recognized industry expert in direct-to-consumer and point-of-care testing technology. In 2006, he joined the start-up team at Canadian Bioenergy Corporation and helped pioneer the development of the renewable fuel industry in Canada. Before HealthTab, he designed and developed cloud-based informatics systems currently in use by some of the world’s leading medical laboratories and instrument manufacturers.

Avricore Health Inc. (OTCQB: AVCRF), closed Wednesday's trading session at $0.12, up 9.0909%, on 11,950 volume with 2 trades. The average volume for the last 3 months is 11,950 and the stock's 52-week low/high is $0.069/$0.48562.

Recent News

Growth Capital Acquisition Corp. (NASDAQ: GCAC)

The QualityStocks Daily Newsletter would like to spotlight Growth Capital Acquisition Corp. (NASDAQ: GCAC).

Cepton Technologies, Inc. , a Silicon Valley-based lidar innovator, announced today that it has decided to cancel its in-person presence at the upcoming CES 2022 from January 5 th to 8 th , 2022, due to concerns over surging cases of Covid / Omicron variant in the U.S. For the safety of its employees, customers and partners, Cepton will move all in-person communications online to share details about its lidar portfolio and discuss its latest developments in intelligent lidar perception, including dynamic and static applications. Particularly, the Cepton team will be available for online meetings to present the Nova and Vista®-X90 lidars, Cepton’s latest automotive-grade lidar sensors tailored to the needs of global automotive OEMs for next-generation advanced driver assistance systems (ADAS) and autonomous driving capabilities.

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on February 2, 2021, with $172.5 million in Trust, and Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT® lidar solutions, on August 5, 2021, announced their entry into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed ‘Cepton Inc.’ and is expected to be listed on the Nasdaq stock exchange under new ticker symbol ‘CPTN’.

The proposed business combination, which has been unanimously approved by the boards of directors of Cepton and Growth Capital, is expected to be completed early in the first quarter of 2022, subject to, among other things, approval by Growth Capital’s stockholders, satisfaction of the conditions stated in the definitive agreement and other customary closing conditions.

Cepton Technologies Inc. is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s proposed merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Growth Capital Acquisition Corp. (NASDAQ: GCAC), closed Wednesday's trading session at $9.97, even for the day, on 27 volume with 3 trades. The average volume for the last 3 months is 27 and the stock's 52-week low/high is $9.55/$9.99.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced a key partnership with DSA Systems, a leading international provider of vehicle system diagnostics and remote OTA technology. The partnership calls for the two companies to collaborate on Mullen’s strategic FIVE EV Crossover Program. MULN is working on its Mullen FIVE offering, which is built on an EV crossover skateboard platform that provides multiple powertrain configurations and trim levels in a design that is Strikingly Different(TM). In the announcement, MULN noted that DSA is a global leader in equipping automotive OEMs with vehicle diagnostics and connectivity, building a renowned reputation for providing monitoring and supporting technologies throughout the entire life cycle of vehicles. The company anticipates using DSA’s underpinning diagnostic technology in all future vehicle programs. “We intend for the Mullen FIVE to have the best 5G OTA technology from DSA, allowing us to remotely diagnose and proactively fix potential vehicle issues,” said Mullen Automotive CEO and chair David Michery in the press release. “OTA updates and fixes promote a greater service experience for customers. Ideally, we will be able to proactively identify a potential vehicle issue, remotely update and fix the issue, all while the vehicle is parked at the customer’s home and not a dealership waiting for service.” To view the full press release, visit https://ibn.fm/FsvL1. There’s a learning curve when it comes to using electric cars. Rather than the internal combustion engines we are all used to, electric vehicles (“EV”) use rechargeable lithium-ion battery packs and electric motors to generate power and torque. The size of the battery pack will determine your EV’s range, as well as how much energy is stored when the vehicle is at rest and how much is fed to the motors once the car is in motion. With large parts of the country capable of reaching extremely low temperatures in the winter, new drivers will have to learn how to maximize range in extremely cold weather. Plenty of electric vehicle models on the market already have more than 200 miles of battery range. And with automakers such as Mullen Automotive Inc. (NASDAQ: MULN) poised to significantly increase their selections of electric vehicles, you won’t have to struggle to find an EV that suits your driving needs.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $5.09, off by 6.0886%, on 631,327 volume with 3,228 trades. The average volume for the last 3 months is 616,819 and the stock's 52-week low/high is $4.92/$19.15.

Recent News

Nemaura Medical Inc. (NASDAQ: NMRD)

The QualityStocks Daily Newsletter would like to spotlight Nemaura Medical Inc. (NASDAQ: NMRD).

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since its founding in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved to create wearable technologies and digital health care solutions that encourage and empower people to take charge of their health and well-being. “The company’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible continuous glucose monitor (‘CGM’) designed to help people with diabetes and prediabetes manage their glucose levels,” reads a recent article. “The company has recently followed up with the release of the MiBoKo application. This service, which has been in development for the past 18 months, seeks to address a significant mass-market opportunity, which the company believes could benefit roughly a third to half of the global population. The MiBoKo application uses a non-invasive glucose sensor to measure and monitor the user’s metabolic health scores, which are based on glucose tolerance or insulin resistance. Prediabetic patients, those facing obesity concerns, or individuals looking to monitor their glucose intake would all benefit from this application.” To view the full article, visit: https://ibn.fm/1aI1g

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Its flagship product, sugarBEAT®, is a wearable, non-invasive and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and prediabetes manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading.

sugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. One of the great advantages of the product, apart from the fact that users no longer need to draw blood samples or prick their fingers, is that a person can wear the CGM patch on whatever day they choose. Existing CGM devices must be implanted under the skin. Wearable disposability is a unique feature of sugarBEAT and a world first, opening up vast potential for changing the way people manage their chronic disease conditions. sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union as a Class 2b Medical Device. The company submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration in 2020 which is currently under review.

Founded in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and well-being. Nemaura’s skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline, such as Lactate Monitoring.

Technologies

Digital Solutions for Weight Loss and Potential Reversal of Type 2 Diabetes

This is a digital program that comes with more than a decade of clinical evidence demonstrating excellent efficacy. The company has combined this with its glucose-monitoring platform to bring a product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.

Glucose Monitoring Solutions for Diabetes Prevention and Reversal

Over 420 million people worldwide are living with diabetes, and prediabetes cases total almost three times that number. Undoubtedly, diabetes is an urgent global health crisis. Combining clinical research with patient-friendly technology, Nemaura’s sugarBEAT product delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.

Continuous Lactate Monitoring for Athletic Performance (Non-Medical)

Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and those who regularly engage in sports are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Nemaura expects to launch its lactate sensor to the sports and personal training market in 2022.

Continuous Lactate Monitoring in Disease State (Medical)

An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura has developed a lactate sensor that is being integrated into the company’s platform, which will be submitted for regulatory clearance upon completion of requisite clinical studies.

Continuous Temperature Monitoring for Viral Infection Detection and Disease Progression

A person’s body temperature says a lot about their health. Several diseases, including COVID-19, are characterized by an increase in body temperature, so temperature monitoring is a vital tool in the detection, diagnosis and prevention of the spread of disease. Nemaura is expecting to submit this adaptation of the device for regulatory clearance in 2022.

Market Opportunity

Obesity and diabetes are two of the major drivers of the current chronic disease epidemic. According to the International Diabetes Federation, there are more than 463 million people living with diabetes worldwide. In the U.S., about 28,000 people are diagnosed with diabetes every week, and more than 34 million suffer from diabetes. Another 88 million Americans have prediabetes. Other industrialized countries show similar numbers based on their populations. In the U.K., 4.8 million people have diabetes, with another diagnosed every two minutes. In Germany, 9.5 million have diabetes, with almost half estimated to be undiagnosed and so at greater risk.

On average, employers and insurers spend more than $9,000 annually on health care for an employee with diabetes, compared to $1,600 annually for a healthy employee. In the U.S. alone, more than $760 billion was spent on diabetes-related health care expenditures during 2019. Nemaura is positioned at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market, and the wearable health-tech sector for weight loss and wellness applications forecast to hit $60 billion by 2023.

Management Team

Dr. Faz Chowdhury has been CEO and chairman of the board of Nemaura Medical since 2013. He has more than 20 years of experience in the pharmaceutical and medical devices industry, taking products from concept to commercial launch. He is sole inventor on more than 100 granted and pending patents and has authored textbook chapters on nano-biosciences for Wiley and Elsevier. He holds a master’s degree in microsystems and nanotechnology from Cranfield University, and a doctorate from the University of Oxford in nano-medicine and drug delivery.

Justin Mclarney is CFO at Nemaura. He most recently was the Senior Director, International Finance at Lands’ End Inc. He also worked for Office Depot as Senior Director of Finance for the largest business unit within the European group. Prior to that, he spent more than 10 years in practice, the majority of which was with Ernst & Young LLP.

Dr. Fred Schaebsdau is Vice President of Strategy & Strategic Alliances at Nemaura. He has more than 15 years of executive experience in the CGM, blood glucose monitoring and insulin delivery industries, including time with Abbott Diabetes Care, as General Manager of Dexcom Germany and at Roche Diabetes Care, where he was Senior Vice-President, Head of Global Strategy and Business Development. The firm he founded is the exclusive distributor in Europe, the Middle East and Africa of UniStrip®, the world’s first generic blood glucose test strip. He is licensed to practice medicine in the U.S. and Germany.

David Scott is Director of Commercial Development and Licensing at Nemaura. He is a trained chemist with over 35 years of experience in the pharmaceutical industry, including deal brokering, marketing, strategic planning, finance, business development and acquisitions. He has also provided licensing training for a number of multinational pharma companies and training organizations and is the author of best-selling report Scrip’s Practical Guide to Pharmaceutical Licensing.

Nemaura Medical Inc. (NASDAQ: NMRD), closed Wednesday's trading session at $4.5, off by 4.4586%, on 69,678 volume with 356 trades. The average volume for the last 3 months is 69,674 and the stock's 52-week low/high is $3.7101/$17.40.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing is anticipated to begin by April of next year. The study will incorporate a double-blinded, randomized, cross-over design, with a placebo control. The length of the study allows the company to evaluate the impact of DehydraTECH-CBD over time as well as the potential for longer-term health benefits. This study is the most comprehensive undertaken by Lexaria. “The hypertension market is valued at $28 billion per year and is expected to continue growing as one of the world's top health problems and as a subset of the larger heart disease market,” the company stated in the press release. “Over 1.1 billion people worldwide suffer from hypertension. Fewer than 1 person in 4 with hypertension have successfully controlled their blood pressure through medications, meaning the potential market for hypertension drugs is much larger than $28 billion per year if an affordable drug was available with few or no side effects. Lexaria believes that its DehydraTECH-CBD may introduce a more tolerable anti-hypertensive treatment option that may be used alone or in combination with other medications, to reduce BP with fewer discouraging and unwanted side effects.” To view the full press release, visit https://ibn.fm/6EBoa

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $3.87, off by 6.5217%, on 709,464 volume with 2,443 trades. The average volume for the last 3 months is 709,464 and the stock's 52-week low/high is $3.779/$12.50.

Recent News

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF)

The QualityStocks Daily Newsletter would like to spotlight Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF).

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR), a propriety software-as-a-service “SaaS” technology company delivering mobile live dealer technology to online gaming operators globally, is emerging as a clear leader in the burgeoning iGaming space. Most recently, the company announced that its total player wagering for November 2021 increased approximately 12% compared to October 2021. Further, monthly active player numbers are up 28%, bet spots have increased over 22%, and the company added three new operators to its platform. This brings the total number of operators using Playgon tech to 26, with eight more waiting in the wings at various stages of integration. “We continue to garner strong interest and onboard operators rapidly as the demand for our product continues to grow at a healthy pace,” said Playgon Games CEO Darcy Krogh. “Player activity and wagering are important metrics of the success of our mobile live-dealer product, and we are delighted with the growth we are experiencing. For the second month in a row, we are delivering record increases in player wagering, which is a direct function of the growing number of users leveraging our platform as we offer our games through some of the largest gaming operators globally.” To view the full article, visit https://ibn.fm/Q0UbH

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) is a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Seamless integration at the operator level allows customer access without requiring the sharing of any sensitive customer data. Playgon games run on any browser and any device as fast and secure as a native app, without requiring any app store download. All that’s needed is a stable internet connection. The gaming experience is identical across all mobile devices. As a true business-to-business digital content provider, the company’s products are scalable turnkey solutions for online casinos, sportsbook operators, location-based operators, media groups, and big database companies.

Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices.

The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more.

Playgon plans to expand the studio to 25 tables in the near term and is working to establish a U.S. strategy. The company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement. As a B2B software supplier, Playgon avoids player acquisition costs.

Games

Live Dealer Casino

Playgon offers the first and only Live Dealer Casino streaming live from Las Vegas. The company brings cutting-edge handheld features and functionality to the mobile generation of gaming enthusiasts who demand a world-class gaming experience on all devices. Playgon’s Blackjack delivers the look and feel of location-based casino tables with features providing players with the most unique user experience. The company’s true-to-life Roulette offers players a clear and uninterrupted view of the dealer, wheel, ball, bets, results, trends and statistics. Players can strategize, place multiple bets, track results and review trends without ever losing focus of the game.

Playgon’s traditional Baccarat and proprietary Tiger Bonus Baccarat™ prove their worth by not only recognizing the need for a prominent product, but by adding elements which separate them from the pack without removing their authenticity. The games mix advances in technology with the traditional game attributes that have resonated and captivated players for hundreds of years.

eTable Games

To lead the rise of mobile-first gaming, Playgon developed a user experience perfected for one-handed play. Providing this next evolution in gaming technology ensures the company’s client operators loyalty from existing customers and is a powerful strategy to attract and retain new players. Playgon’s VEGAS LOUNGE™ brings together an innovative mix of games, technology and gameplay that offers players an authentic experience and real Las Vegas casino fun every time, everywhere.

Daily Fantasy Sports

Playgon’s Daily Fantasy Sports (DFS) are a subset of fantasy sport games which typically target a younger demographic. DFS provides iGaming operators a turnkey fantasy sports platform that can quickly go to market, integrate with the operator’s existing operations and services, and be customized to match and enhance the operator’s brand. The platform is mobile and desktop friendly, built for regulated market environments, and allows operators to monetize users through a network of shared liquidity.

Market Outlook

Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos. This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, as well as tech like digital wallets and digital gameplay that underpins Playgon Games. The company has been described as “Netflix + Vegas, all in one.”

The online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25 percent year over year. The current global online Live Casino TAM is estimated at about $6 billion annually, and revenue is forecast to reach more than $8 billion by 2023 and more than $13 billion by 2027.

Management Team

Darcy Krogh is CEO of Playgon Games. He is a veteran of the iGaming industry with over 20 years of experience. In 1999, he co-founded Chartwell Technology Inc., which pioneered the development of browser-based digital content for the iGaming industry. After that company was sold to Amaya Gaming Group, he served as VP Business Development with Amaya. In 2016, he started Playgon Games (formally Global Daily Fantasy Sports Inc.) as President and CEO. His experience in the online gaming industry includes sales and marketing, relationship management, corporate finance, M&A, and strategic corporate development.

Guido Ganschow is President of Playgon Interactive. He has more than 12 years of experience in creating real-time Live Dealer technology and platforms and was the co-founder and Creative Director for a Macau-based casino consortium. Between 2008 and 2014, he successfully created and established Live Dealer platform businesses in Asia and Europe, and executed commercial partnerships, sales, and integration of the Live Dealer solution with major global gaming brands, including Ho Gaming Group, Chartwell Technology and Amaya Gaming Group.

Steve Baker is COO of Playgon. He is a former VP Operations for Shaw Communications, where he was directly involved in video streaming, home entertainment, new products, sales and M&A. He oversaw revenue growth from $300 million to $2.8 billion and employee growth from 350 to 13,000. He has broad experience and a proven record in development and implementation of cost effective and efficient growth strategies transitioning businesses from development to operations.

Harry Nijjar is CFO of Playgon Games. He is currently a Managing Director with Malaspina Consultants Inc. and provides CFO and strategic financial advisory services to his clients across many industries. This experience has allowed him to help his clients successfully navigate the regulatory and financial environments within which they operate. Mr. Nijjar holds a CPA-CMA designation from the Chartered Professional Accountants of British Columbia.

Playgon Games Inc. (PLGNF), closed Wednesday's trading session at $0.2475, off by 2.9412%, on 112,200 volume with 6 trades. The average volume for the last 3 months is 112,200 and the stock's 52-week low/high is $0.197/$0.6282.

Recent News

Asia Broadband Inc. (OTC: AABB)

The QualityStocks Daily Newsletter would like to spotlight Asia Broadband Inc. (AABB).

A new report by the World Gold Council (“WGC”) highlights that investors have begun to shift towards assets that are less liquid than conventional investments to improve portfolio performance. The council states that investors are also getting involved in riskier investment alternatives seeking higher yields, even with fixed income investments making up a large chunk of their portfolios. The council believes that the investment appeal for gold will strengthen amid the shift to less liquid and riskier assets, given its usefulness as a highly liquid diversifier, which can decrease portfolio volatility. Anecdotal evidence from international conferences and investors, as well as data from Mercer and the Greenwich Coalition also suggests that investments in alternatives and assets such as infrastructure and real assets have been increasing. In its conclusion, the gold council notes that the metal would have reduced overall volatility of portfolios, adding that the use of gold to build positions in some distressed assets would have grown last year’s returns. While most assets ended 2020 modestly higher, gold finished the year 25% higher, all on its own. This paints an optimistic picture for the future of mining companies such as Asia Broadband Inc. (OTC: AABB), which are focused on precious metals extraction.

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production, supply and sale of precious and base metals, primarily to Asian markets.

The company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate its innovative distribution process from the production and supply of precious and base metals in Mexico to client sales networks in Asia. This vertically integrated approach to sales transactions differentiates Asia Broadband from its competitors in the mining space.

Development Program in Colima, Mexico

In October 2020, Asia Broadband announced its acquisition of a high potential mineral property in the state of Colima, Mexico. Per the press release, previous geophysics and groundwork have revealed strong indications of significant mineralization in multiple sectors of the property.

The company recently began the construction of exploration and development facilities and infrastructure roads on its Colima property, and plans are underway to extend previous geophysics and groundwork on the property. In January 2021, Asia Broadband announced its allocation of $10 million for the initial development program, with the aim of accelerating operations at the Colima site toward production.

Positioned in a major gold-iron-copper production area, the company’s Colima property is situated approximately 25 kilometers east of the Pena Colorada mine in Minatitlan, Mexico. It is advantageously located, with direct access to main Highway #3, and the property also has an essential natural water supply.

AABB Gold Token

In December 2020, Asia Broadband announced its entry into a definitive development agreement with Core State Holdings Corp., a digital assets and crypto wallet creator, to produce a white label gold-backed cryptocurrency coin. The AABB Gold token is an ERC-20 token being developed on the Ethereum blockchain.

In a February 2021 news release, the company provided a development update on the cryptocurrency token, noting that Core State Holdings Corp. “is continuing to modify the set-up and move through the final stages of testing of the iOS and Android AABB Wallet applications, including the implementation of an application interface to allow users to see the real-time exchange rate of gold that backs the price of the AABB Gold token set at one-tenth of a gram or approximately $5.80 USD.”

Core State Holdings Corp. has also continued to enhance www.AABBGoldToken.com, which the company notes will be the go-to knowledge base for all information concerning the soon-to-be launched AABB Wallet and AABB Gold token.

AABB’s primary goal for the token is to become a worldwide standard of exchange – secured and trusted with gold backing – by expanding circulation and targeting large population and high growth markets globally, including China and East Asia.

Asia Broadband Inc. (AABB), closed Wednesday's trading session at $0.1625, off by 11.1536%, on 72,756,359 volume with 5,262 trades. The average volume for the last 3 months is 72.731M and the stock's 52-week low/high is $0.0079/$0.659.

Recent News

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

New research has found evidence that an extensive range of early onset psychiatric issues like ADHD, bulimia, dyslexia, anxiety and depression are primarily caused by psychological, social and biological factors. The objective of the study, which was conducted by scientists at McGill University, was to better understand the cause of psychiatric disorders. With regard to the factors that may cause these disorders to develop, the psychological factor is associated with temperament, in particular, difficulty controlling emotions and the tendency toward impulsivity. The social factor suggests the crucial role of early childhood abuse or neglect while the biological factor is in the form of individual variability in the dopamine reward pathway in the brain. Mental health is attracting a lot of interest in the research community, and companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are focused on coming up with new formulations that will mark a paradigm shift from the way these conditions have been managed for decades.

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded AudioTranscriptionist.com and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded Cannabase.io, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Wednesday's trading session at $0.1156, off by 17.4286%, on 1,504,478 volume with 395 trades. The average volume for the last 3 months is 1.498M and the stock's 52-week low/high is $0.01/$2.20.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

  • Delic Holdings subsidiary, Ketamine Wellness Centers, announced plans to open two new clinics in the coming weeks
  • The clinics, to be located in Salt Lake City, Utah and Reno, Nevada will take KWC’s total clinic count to 14, forming part of the company’s plan to open 13 new ketamine infusion clinics across the country over the next 18 months
  • Following Delic’s keynote ‘Meet Delic’ conference on Nov. 6-7, CEO Matt Stang announced plans to attend the upcoming HC Wainwright Bioconnect Virtual Conference as well as CEM’s 8th annual AlphaNorth Capital Conference in January 2022

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leading psychedelic wellness platform committed to bringing science-backed benefits to its many stakeholders, has revealed that its wholly owned ketamine infusion clinic chain, Ketamine Wellness Centers LLC (“KWC”), will open two new clinics in Salt Lake City, Utah and Reno, Nevada, by February 2022. Ketamine Wellness Centers LLC, which was acquired by Delic Holdings in September 2021, currently boasts 10 ketamine infusion treatment clinics located across eight U.S. states, having cumulatively delivered over 60,000 treatments to date across Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas and Washington. Rep. Earl Blumenauer is asking fellow legislators to join him in urging the DEA to permit patients suffering from terminal illnesses to use psilocybin as part of their treatment, without fear of being federally prosecuted. In a letter circulated by Blumenauer, he notes that there are federal as well as state right-to-try legislations that should allow particular patients to access the psychedelic as an investigational treatment. In a separate interview, Blumenauer stated that he was excited about the implementation of a psilocybin therapy program being established in Oregon, his home state, as well as the advancements being made in psychedelic research. Many companies, including Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), are also offering ketamine infusions in jurisdictions where such treatments are legal, and many patients are benefiting from the remedies.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Wednesday's trading session at $0.111, off by 4.475%, on 70,758 volume with 26 trades. The average volume for the last 3 months is 70,758 and the stock's 52-week low/high is $0.10/$1.038.

Recent News

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently announced its acquisition of Hearing Assist II LLC (“HearingAssist”). A long established leader in the market, HearingAssist has sold over 500,000 hearing aids since 2008 and has generated upwards of $72 million in top-line revenues since 2018, transforming into Walmart’s largest hearing aid supplier in the process. The acquisition will enable InnerScope to accelerate its revenue and growth strategy, as it consolidates the sales generated by HearingAssist’s hearing product kiosks, which are currently in place across 757 Walmart stores in five states. Following the acquisition, the company also revealed plans to release a joint marketing campaign, seeking to build upon HearingAssist’s brand message as “America’s No. 1 Affordable Hearing Brand.” “Today is a tremendous milestone for InnerScope. I’m delighted to welcome the HearingAssist team, who share our passion for providing convenient and affordable hearing products for the tens of millions of Americans who suffer from hearing loss,” Matthew Moore, president and CEO of InnerScope, was quoted in a recent article. “The HearingAssist acquisition is another meaningful step in advancing our strategy to grow as a leader and innovator in the direct-to-consumer hearing aid market.” To view the full article, visit https://ibn.fm/6tMLQ

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb).

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Wednesday's trading session at $0.0098, off by 3.9216%, on 45,599,020 volume with 531 trades. The average volume for the last 3 months is 45.599M and the stock's 52-week low/high is $0.0001/$0.098.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading